Shell Asset Management’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
CCM
EAM
RF
EC
Shell Asset Management's EVH Position: Q3 2025 in Review
Shell Asset Management reduced its Evolent Health (EVH) stake by 58% in Q3 2025, selling an estimated $29.8K and leaving 2,222 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.
Shell Asset Management first reported a position in EVH in Q2 2020 and has held it in 21 quarters since. The position peaked at $639K in Q3 2023. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.
- Shell Asset Management held 2,222 shares of Evolent Health worth $19K as of Q3 2025.
- Shell Asset Management sold 3,066 Evolent Health shares in Q3 2025, an estimated $29.8K.
- Evolent Health made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1042 holding.
- Shell Asset Management first reported a position in Evolent Health in Q2 2020 and has held it in 21 quarters since.
- Shell Asset Management's Evolent Health position peaked at $639K in Q3 2023.
- 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.